![Tom Strange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Strange
Private Equity Investor bei
iCON Infrastructure LLP
Profil
Tom Shaw Le Strange is currently a Director at iCON Infrastructure LLP.
Previously, he was a Director at MiroBio Ltd. in 2022.
He graduated from the University of Cambridge in 2012 and completed his undergraduate degree at The University of Nottingham in 2008.
Aktive Positionen von Tom Strange
| Unternehmen | Position | Beginn |
|---|---|---|
iCON Infrastructure LLP
 iCON Infrastructure LLP Investment ManagersFinance iCON Infrastructure invests in mid-market companies across Europe and North America. The firm targets companies operating in the fields of transportation, utilities, telecommunication, energy & environment and social infrastructure sectors. It provides financing for buyout transactions. | Private Equity Investor | 01.06.2023 |
Ehemalige bekannte Positionen von Tom Strange
| Unternehmen | Position | Ende |
|---|---|---|
MiroBio Ltd.
 MiroBio Ltd. BiotechnologyHealth Technology Develops therapeutics for auto-immune diseases | Private Equity Investor | 01.11.2022 |
Ausbildung von Tom Strange
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
99
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iCON Infrastructure LLP
iCON Infrastructure LLP Investment ManagersFinance iCON Infrastructure invests in mid-market companies across Europe and North America. The firm targets companies operating in the fields of transportation, utilities, telecommunication, energy & environment and social infrastructure sectors. It provides financing for buyout transactions. | Finance |
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Develops therapeutics for auto-immune diseases | Health Technology |
